mitoxantrone has been researched along with Glioblastoma with Sarcomatous Component in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mitoxantrone is a drug with potent in vitro activity against malignant brain tumor cell lines; however, its effectiveness as a systemic agent has been hampered by poor central nervous system penetration and dose-limiting myelosuppression." | 1.31 | Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats. ( Brem, H; DiMeco, F; Li, KW; Olivi, A; Tyler, BM; Wolf, AS, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiMeco, F | 1 |
| Li, KW | 1 |
| Tyler, BM | 1 |
| Wolf, AS | 1 |
| Brem, H | 1 |
| Olivi, A | 1 |
1 other study available for mitoxantrone and Glioblastoma with Sarcomatous Component
| Article | Year |
|---|---|
Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats.
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Contraceptive Agents; Gliosarcoma; Humans; K | 2002 |